
Every newborn and infant under 8 months old should be given a "powerful" new drug to protect them from respiratory syncytial virus (RSV) this upcoming season, the Centers for Disease Control and Prevention (CDC) recommended Thursday (Aug. 3).
The new drug isn't a vaccine, but rather contains lab-made proteins that latch onto the virus and block infection.